Predicting the next round of drugs for Medicare price negotiation

Authors: Matthew Vogel, Adam Tellier, Rena M. Conti

Published: 2024-12-04

DOI: 10.1126/scitranslmed.adq5711

Source: Full article

---

Abstract

There is uncertainty regarding which brand-name prescription drugs will have their prices negotiated by Medicare in 2025. This Viewpoint analyzes the process that will be used to select the next 15 drugs for price negotiation.